Prostate Cancer
Gold seed fiducials in analysis of linear and rotational displacement of the prostate bed - Abstract
January 16, 2014
Value of prostate multiparametric magnetic resonance imaging for predicting biopsy results in first or repeat biopsy - Abstract
January 16, 2014
Urinary PCA3 as a predictor for prostate cancer in a cohort of 3073 men undergoing initial prostate biopsy - Abstract
January 16, 2014
Improving detection of clinically significant prostate cancer: MRI/TRUS fusion-guided prostate biopsy - Abstract
January 16, 2014
Tumor target volume for focal therapy of prostate cancer: Does multiparametric MRI allow for a reliable estimation? - Abstract
January 16, 2014
Preclinical and clinical development of DNA vaccines for prostate cancer - Abstract
January 16, 2014
Improving outcome of surgical procedures is not possible without adequate quality measurement - Abstract
January 16, 2014
Deferred permanent prostate seed brachytherapy does not affect PSA outcome: Results from a large retrospective cohort - Abstract
January 16, 2014
Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival - Abstract
January 16, 2014
Long term rectal function after high-dose prostate cancer radiotherapy: Results from a prospective cohort study - Abstract
January 16, 2014
Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT) - Abstract
January 16, 2014
Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients - Abstract
January 16, 2014